American International Group, GameStop, Gilead Sciences Downgraded

American International Group, GameStop, Gilead Sciences received bearish analyst attention ahead of today's open

Mar 13, 2017 at 10:10 AM
facebook X logo linkedin


Analysts are weighing in on insurance giant American International Group Inc (NYSE:AIG), video game retailer GameStop Corp. (NYSE:GME), and drug stock Gilead Sciences, Inc. (NASDAQ:GILD). Here's a quick roundup of today's bearish brokerage notes on AIG, GME, and GILD shares.

Deutsche Bank Downgrades AIG Stock

AIG has swung 0.2% higher to trade at $62.89, even after a downgrade to "sell" from "hold" at Deutsche Bank, which also trimmed its price target by $4 to $57. The brokerage firm specifically expressed concern the board has not yet found a replacement for outgoing CEO Peter Hancock, which "indicates indecision." While the stock has given back some ground since topping out at a post-financial-crisis high of $67.47 in January, it still sports a 19% year-over-year advance. Meanwhile, analysts' outlooks are mixed, with half the brokerage firms calling American International Group Inc a "buy" or better, and the other half deeming it just a "hold." 

GameStop Stock Slide Continues 

Telsey Advisory Group downgraded GME shares to "market perform" from "outperform," and cut its price target to $27 from $28. At last check, the stock was off 2.6% at $24.52, bringing its 12-month deficit to 20.3%. As such, GameStop Corp. remains a name that could fall victim to additional bearish attention from the Street, since the vast majority of covering brokerage firms still maintain a "buy" or better opinion on the long-time underperforming stock. 

Goldman Sachs Trims Outlook for Gilead Sciences

GILD is continuing its downtrend, last seen 0.8% lower at $67.65, after Goldman Sachs reduced its price target to $68 from $70. The shares have been stair-stepping lower since flirting with triple-digit territory last April, yet options traders continue to buy calls at an alarming rate. Specifically, Gilead Sciences, Inc. has a 10-day call/put volume ratio of 3.27 at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), which tops 90% of all readings from the past year. Elsewhere, the drugmaker has been thrust into the M&A rumor mill.

Get a jump-start on the day's stock market news with Schaeffer's free Opening View newsletter.
 

Target Effortless Triple-Digit Gains Every Sunday Evening For Life!

This is your chance to triple your profit potential on Sunday evenings, without spending all your free time watching the market.

On Sundays, as a Weekend Plus subscriber, you’ll get up to 6 trades every Sunday, each targeting gains of 200% or more.

Start targeting gains like the ones our subscribers have seen recently, including:

213.3% GAIN on AutoNation calls
100.0% GAIN on Monster Beverage calls
100.4% GAIN on Walgreens Boots Alliance puts
100.4% GAIN on ON Semiconductor calls
257.7% GAIN on Dell calls

101.0% GAIN on Apollo Global Management calls
103.6% GAIN on JP Morgan  Chase calls
105.3% GAIN on DraftKings calls
101.3% GAIN on Airbnb calls
203.0% GAIN on Shopify calls
102.0% GAIN on Cboe Global Markets calls
100.9% GAIN on Boeing calls
102.1% GAIN on Microsoft puts
102.3% GAIN on First Solar calls
101.5% GAIN on PulteGroup calls
101.0% GAIN on Apple calls
209.4% GAIN on NXP Semiconductors calls
100.8% GAIN on Uber Technologies calls
100.4% GAIN on Academy Sports and Outdoors puts
102.2% GAIN on Trade Desk calls
100.8% GAIN on DoorDash calls
100.0% GAIN on Camping World Holdings puts
100.0% GAIN on Cboe Global Markets calls
100.2% GAIN on C3.ai calls
238.5% GAIN on Oracle calls

 
 
 


 
 

Rainmaker Ads CGI